{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicdzg2zqhmqxrqt6nplc4fk4ybx6tk5ossunl2ueosatz3qyg5o4u",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3me5qahnocox2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreievxr4lxyp6jn6rd4nfthgsaj7dcfcawyqsf5srb3ycg4uivgnigu"
    },
    "mimeType": "image/jpeg",
    "size": 297749
  },
  "path": "/news/2026-02-paper-urges-caution-fda-phase.html",
  "publishedAt": "2026-02-05T19:50:03.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Medical research"
  ],
  "textContent": "Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals as well as alleviating animal suffering. But according to a new paper co-written by a University of Illinois Urbana-Champaign expert in legal issues surrounding cutting-edge medical developments, such a novel approach to drug trials needs to be implemented judiciously and with caution.",
  "title": "New paper urges caution as FDA plans to phase out animal testing in drug development"
}